Broadcom Inc. Total Cost of Revenue increased by 6.7% to $6.15B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.0%, from $4.77B to $6.15B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 18.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.55B | $2.58B | $2.77B | $2.66B | $2.66B | $2.78B | $3.00B | $2.91B | $2.62B | $2.71B | $2.89B | $4.59B | $4.71B | $4.72B | $5.05B | $4.77B | $4.81B | $5.25B | $5.77B | $6.15B |
| QoQ Change | — | +1.1% | +7.3% | -4.0% | +0.3% | +4.5% | +7.9% | -3.1% | -10.1% | +3.6% | +6.5% | +58.8% | +2.7% | +0.1% | +7.1% | -5.6% | +0.8% | +9.2% | +9.8% | +6.7% |
| YoY Change | — | — | — | — | +4.3% | +7.8% | +8.5% | +9.6% | -1.7% | -2.6% | -3.9% | +57.5% | +79.9% | +73.9% | +74.9% | +4.0% | +2.0% | +11.3% | +14.1% | +29.0% |